Aloe-Emodin Quinone Pretreatment Reduces Acute Liver Injury Induced by Carbon Tetrachloride
Authors: Arosio B.1; Gagliano N.1; Fusaro L.M.P.1; Parmeggiani L.1; Tagliabue J.1; Galetti P.1; de Castri D.2; Moscheni C.1; Annoni G.3
Source: Basic & Clinical Pharmacology & Toxicology, Volume 87, Number 5, 1 November 2000 , pp. 229-233(5)
Publisher: Blackwell Publishing
Abstract:
: Aloe contains several active compounds including aloin, a C-glycoside that can be hydrolyzed in the gut to form aloe-emodin anthrone which, in turn, is auto-oxidized to the quinone aloe-emodin. On the basis of the claimed hepatoprotective activity of some antraquinones, we studied aloe-emodin in a rat model of carbon tetrachloride (CCl4) intoxication, since this xenobiotic induces acute liver damage by lipid peroxidation subsequent to free radical production. Twelve rats were treated with CCl4 (3 mg/kg) intraperitoneally and six were protected with two intraperitoneally injections of aloe-emodin (50 mg/kg; CCl4+aloe-emodin); six other rats were only aloe-emodin injected (aloe-emodin) and six were untreated (control). Histological examination of the livers showed less marked lesions in the CCl4+aloe-emodin rats than in those treated with CCl4 alone, and this was confirmed by the serum levels of L-aspartate-2-oxoglutate-aminotransferase (394±38.6 UI/l in CCl4, 280±24.47 UI/l in CCl4+aloe-emodin rats; P<0.05). We also quantified changes in hepatic albumin and tumour necrosis factor-
mRNAs. Albumin mRNA expression was significantly lower only in the liver of CCl4 rats (P<0.05 versus control) and was only slightly reduced in the CCl4+aloe-emodin rats. In contrast tumour necrosis factor-
mRNA was significantly higher (P<0.05) in the CCl4 than the control rats and almost equal in the CCl4+aloe-emodin, aloe-emodin and control groups. In conclusion, aloe-emodin appears to have some protective effect not only against hepatocyte death but also on the inflammatory response subsequent to lipid peroxidation.
Document Type: Original article
Affiliations: 1: Department of Internal Medicine, Milano University Study and Hospital Maggiore IRCCS, Milano, 2: Center Maria Branca, Milano, Italy 3: School of Medicine, Milano-Bicocca University Study, and
The full text article is temporarily unavailable.
We apologise for the inconvenience. Please try again later.

Click here for Page Help